×
0 0 0 0 0 0 0 0
Stockreport

Crispr stock up 8% as company says FDA accepted new-drug application [MarketWatch]

NEWS CORP (NWS)  More Company Research Source: MarketWatch
US:NASDAQ Investor Relations: investors.newscorp.com/investor-relations
PDF Crispr stock up 8% as company says FDA accepted new-drug application Shares of Crispr Therapeutics AG CRSP, -0.57% rose more than 8% in the extended session Wednesday after the company and Vortex Pharmaceuticals Inc. VRTX, -4.97% said the Food and Drug Administration has lifted a clinical hold and has accepted a new-drug application for their gene-editing treatment for sickle-cell disease. Shares of Vortex rose 0.6% after ending the regular trading day down 5%. Crispr shares closed 0.6% lower. Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here. [Read more]

IMPACT SNAPSHOT EVENT TIME: NWS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
NWS alerts
from News Quantified
Opt-in for
NWS alerts

from News Quantified
Opt-in for
NWS alerts

from News Quantified